References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Burgesetal(1987)Calciumchannelblockingpropertiesofamlodipineinvascularsmoothmuscleandcardiacmuscleinvitro:evidenceforvoltagemodulationofvasculardihydropyridinereceptors.J.Cardiovasc.Pharmacol.9110PMID:2434785
Yoshidaetal(2003)AntiproliferativeeffectofCa2+channelblockersonhumanepidermoidcarcinomaA431cells.Eur.J.Pharmacol.47223PMID:12860469
Tobaetal(2005)Calciumchannelblockadesexhibitanti-inflammatoryandantioxidativeeffectsbyaugmentationofendothelialnitricoxidesynthaseandtheinhibitionofangiotensinconvertingenzymeintheNG-nitro-L-argininemethylester-inducedhypeHypertens.Res.28689PMID:16392774
Keywords:Amlodipinebesylate,supplier,Ca2+,channel,blockers,L-type,Calcium,CaV,Channels,L-Type,voltage-gated,voltage-dependent,Norvasc,Voltage-gated,Calcium,Channels,Voltage-gated,Calcium,Channels,TocrisBioscience